InvestorsHub Logo

FELLER

01/31/17 6:40 PM

#44353 RE: rstar #44349

Since you said "why they were given that valuation" -- keep in mind $2.87 Billion is their ACTUAL "Market Value" based on their current stock price of $115/share.

Goldman Sachs valued them at $349/share. That's more than TWICE what they're trading for right now.

So... This is why I feel catching up to GWPH and being "worth" half of their current day value is possible for OWCP by Q3 or Q4, as I anticipate hearing about a product launch of the Tablet -- which may or may not be a Tablet to treat SEVERAL things like PTSD, Fibromyalgia, Migraines, etc.

zombywolf

01/31/17 6:55 PM

#44360 RE: rstar #44349

But the MM's let them run, unlike here.

onco

01/31/17 7:58 PM

#44383 RE: rstar #44349

Agree AXIM better we have more going very surprised are trading is following their pattern IMO

FELLER

01/31/17 8:12 PM

#44385 RE: rstar #44349

Just a reminder too... Miriam Sani... She'll help OWCP get FDA approval.

The timeline is currently unknown, of course. But, she'll be a great asset on that quest.